SCHEMBL10167906

SCHEMBL10167906

Cc1ccc2c(ccc(C)[n+]2C)c1

nearest known ligand 0.50

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CYP1A2 P05177 6/20 0.50
CYP2A6 P11509 5/20 0.50
TDP1 Q9NUW8 2/20 0.43
KDM4E B2RXH2 5/20 0.36
SMN1; SMN2 Q16637 3/20 0.36
LMNA P02545 2/20 0.36
CYP3A4 P08684 2/20 0.36
KMT2A Q03164 2/20 0.36
MEN1 O00255 1/20 0.36
USP2 O75604 1/20 0.36
MAPT P10636 1/20 0.36
APEX1 P27695 1/20 0.36
CASP1 P29466 1/20 0.36
BRCA1 P38398 1/20 0.36
HTT P42858 1/20 0.36
CASP7 P55210 1/20 0.36
HBB P68871 1/20 0.36
HIF1A Q16665 1/20 0.36
ALDH1A1 P00352 2/20 0.35
NCK1 P16333 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL30206597 0.81 KDM4E (0.48) CYP1A2CYP2A6TDP1KDM4ESMN1; SMN2
SCHEMBL10168165 0.79 CYP2A6 (0.40) CYP2A6TDP1KDM4ESMN1; SMN2LMNA
SCHEMBL10168166 0.79 CYP1A2 (0.40) CYP1A2CYP2A6KDM4ESMN1; SMN2LMNA
SCHEMBL9724136 0.77 CYP2A6 (0.48) CYP1A2CYP2A6TDP1KDM4ESMN1; SMN2
SCHEMBL30968718 0.76 SYNJ2 (0.46) SMN1; SMN2LMNAKMT2AMEN1MAPT
SCHEMBL13144480 0.76 ACHE (0.54) CYP1A2CYP2A6TDP1KDM4ELMNA
SCHEMBL21412991 0.76 SYNJ2 (0.46) SMN1; SMN2LMNAKMT2AMEN1MAPT
SCHEMBL17187221 0.75 CYP2A6 (0.50) CYP1A2CYP2A6TDP1KDM4ESMN1; SMN2
SCHEMBL7936307 0.74 KDM4E (0.46) CYP1A2CYP2A6TDP1KDM4ESMN1; SMN2
SCHEMBL30929898 0.73 ACHE (0.47) CYP2A6TDP1KDM4ESMN1; SMN2LMNA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1330456-B9 N8,N13 -DISUBSTITUTED QUINO[4,3,2-KL]ACRIDINIUM SALTS AS THERAPEUTIC AGENTS CANCER REC TECH LTD (GB) 2012-01-25 EP disclosed
EP-1330456-B1 N8,N13 -DISUBSTITUTED QUINO[4,3,2-KL]ACRIDINIUM SALTS AS THERAPEUTIC AGENTS CANCER REC TECH LTD (GB) 2011-06-15 EP disclosed